Skip to contentC
Cumberland Pharmaceuticals Inc
C
CPIXCumberland Pharmaceuticals Inc Q1 2019 · 10-Q
Revenue$9.42M$9.42Mno prior Q1 2018 on file Net Income-$566.81K-$566.81Kno prior Q1 2018 on file EPS Diluted-$0.04-$0.04no prior Q1 2018 on file Operating Income-$1,373,424— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,789,063— Margins · derivedOperating margin-14.6%
Net margin-6.0%
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end